{"id":"telbivudine-treatment","safety":{"commonSideEffects":[{"rate":null,"effect":"Myopathy"},{"rate":null,"effect":"Elevated creatine kinase"},{"rate":null,"effect":"Lactic acidosis"},{"rate":null,"effect":"Hepatitis flare"},{"rate":null,"effect":"Nausea"},{"rate":null,"effect":"Fatigue"}]},"_chembl":null,"_dailymed":null,"mechanism":{"_ai_source":"claude-haiku-4.5","explanation":"Telbivudine is a thymidine nucleoside analog that inhibits hepatitis B virus (HBV) reverse transcriptase, an enzyme essential for viral DNA synthesis. By incorporating into the growing HBV DNA chain, it causes chain termination and reduces viral load in patients with chronic hepatitis B infection.","oneSentence":"Telbivudine is a nucleoside reverse transcriptase inhibitor that blocks hepatitis B virus reverse transcriptase, preventing viral replication.","_ai_confidence":"medium"},"_scrapedAt":"2026-03-27T23:38:35.935Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Chronic hepatitis B infection"}]},"trialDetails":[{"nctId":"NCT07459426","phase":"","title":"Entecavir Resistance-Associated Mutations in Chronic HBV Patients in Turkey (STREAM Study)","status":"NOT_YET_RECRUITING","sponsor":"Yaşar Bayındır, MD","startDate":"2026-03-15","conditions":"Hepatitis B, Chronic","enrollment":700},{"nctId":"NCT03736265","phase":"NA","title":"Carvedilol for Prevention of Esophageal Varices Progression","status":"UNKNOWN","sponsor":"Beijing Friendship Hospital","startDate":"2017-10-09","conditions":"Cirrhosis, Liver, Portal Hypertension","enrollment":240},{"nctId":"NCT00051090","phase":"NA","title":"Treatment of Hepatitis B Virus (HBV) Before Beginning Anti-HIV Drugs in Patients With Both HBV and HIV","status":"WITHDRAWN","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"","conditions":"HIV Infections, Hepatitis B","enrollment":""},{"nctId":"NCT05021406","phase":"NA","title":"Extension Study of Carvedilol RCT Study","status":"UNKNOWN","sponsor":"Beijing Friendship Hospital","startDate":"2021-01-08","conditions":"Liver Cirrhosis, Portal Hypertension","enrollment":240},{"nctId":"NCT03491553","phase":"PHASE2","title":"Safety, Tolerability and Antiviral Activity of Selgantolimod in Virally-Suppressed Participants With Chronic Hepatitis B","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"2018-04-06","conditions":"Chronic Hepatitis B","enrollment":48},{"nctId":"NCT04724785","phase":"","title":"Real World Study About Anti-viral Regimen Adjustment on Achieving Complete Response in CHB Patients","status":"UNKNOWN","sponsor":"The Second Affiliated Hospital of Chongqing Medical University","startDate":"2020-12-01","conditions":"Sustained Virologic Response, Hepatitis B, Chronic","enrollment":10000},{"nctId":"NCT01410630","phase":"","title":"FLT-PET/CT vs FDG-PET/CT for Therapy Monitoring of Diffuse Large B-cell Lymphoma","status":"COMPLETED","sponsor":"Jonsson Comprehensive Cancer Center","startDate":"2017-09-07","conditions":"Lymphoma, Lymphoma, Non-Hodgkin, Large B Cell Diffuse Lymphoma","enrollment":66},{"nctId":"NCT03366571","phase":"","title":"Improvement of Hard Endpoint in Chronic Hepatitis B Patients Treated With Antiviral Therapy","status":"UNKNOWN","sponsor":"Beijing Friendship Hospital","startDate":"2016-01","conditions":"Chronic Hepatitis B","enrollment":600},{"nctId":"NCT04650828","phase":"","title":"TDF Combined With LDT for the Treatment of HBeAg-positive Hepatitis B Patients With Poor Response to TDF for 12 Months","status":"UNKNOWN","sponsor":"Third Affiliated Hospital, Sun Yat-Sen University","startDate":"2020-12-01","conditions":"Chronic Hepatitis B","enrollment":200},{"nctId":"NCT01935635","phase":"PHASE1, PHASE2","title":"A Clinical Trial on HB-Vac Activated-DCs Combined With Peg-IFN or NAs in CHB","status":"COMPLETED","sponsor":"Third Affiliated Hospital, Sun Yat-Sen University","startDate":"2015-01","conditions":"Chronic Hepatitis B","enrollment":400},{"nctId":"NCT03116542","phase":"NA","title":"18F-FLT (PET/CT) in Prefibrotic/Early Primary Myelofibrosis and Essential Thrombocythemia","status":"UNKNOWN","sponsor":"Hamad Medical Corporation","startDate":"2017-05-07","conditions":"Essential Thrombocythemia, Primary Myelofibrosis, Fibrotic Stage, Primary Myelofibrosis, Prefibrotic Stage","enrollment":21},{"nctId":"NCT00142298","phase":"PHASE3","title":"Telbivudine in Adults Previously Treated in Idenix-Sponsored Telbivudine Studies","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2005-03","conditions":"Chronic Hepatitis B","enrollment":1869},{"nctId":"NCT01943799","phase":"PHASE2","title":"Safety and Efficacy of GS-4774 for the Treatment of Chronic Hepatitis B","status":"COMPLETED","sponsor":"Gilead Sciences","startDate":"2013-09-13","conditions":"Chronic HBV Infection","enrollment":178},{"nctId":"NCT02058108","phase":"PHASE3","title":"Study of Efficacy and Safety, Tolerability and Pharmacokinetics of Telbivudine in Children and Adolescents With Compensated Chronic Hepatitis B Virus Infection","status":"TERMINATED","sponsor":"Novartis Pharmaceuticals","startDate":"2014-10-31","conditions":"Chronic Hepatitis B","enrollment":53},{"nctId":"NCT03969017","phase":"PHASE2","title":"Combination Treatment of NAs and Peg IFN α-2b for Hepatitis B Related, Compensatory Cirrhosis Patients","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2019-06-17","conditions":"Cirrhosis of Liver Due to Hepatitis B (Disorder)","enrollment":84},{"nctId":"NCT03977987","phase":"","title":"Maternal Antiviral Treatment and Infants Immunoprophylaxis in the Prevention of Mother-to-child Transmission","status":"COMPLETED","sponsor":"Huashan Hospital","startDate":"2011-01-01","conditions":"Hepatitis B","enrollment":233},{"nctId":"NCT02774837","phase":"PHASE4","title":"Tenofovir Versus Tenofovir + Telbivudine for Chronic Hepatitis B","status":"UNKNOWN","sponsor":"Seng Gee Lim","startDate":"2016-04","conditions":"Chronic Hepatitis B","enrollment":146},{"nctId":"NCT01379508","phase":"PHASE4","title":"Telbivudine or Tenofovir Treatment in HBeAg-negative Chronic Hepatitis B Patients Based on the Roadmap Concept","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2011-03-21","conditions":"Chronic Hepatitis B","enrollment":241},{"nctId":"NCT02338674","phase":"PHASE1, PHASE2","title":"TDF and LdT in Immune-tolerant CHB Patients Awaiting Assisted Reproduction","status":"COMPLETED","sponsor":"Fuzhou General Hospital","startDate":"2014-10","conditions":"Hepatitis B, Chronic","enrollment":121},{"nctId":"NCT03468907","phase":"PHASE4","title":"The Safety of Anti-viral Therapy in Preventing HBV MTCT in Pregnant Women After Discontinuation","status":"COMPLETED","sponsor":"Third Affiliated Hospital, Sun Yat-Sen University","startDate":"2015-06-01","conditions":"Hepatitis B, Chronic","enrollment":111},{"nctId":"NCT02019966","phase":"","title":"A Korean Cohort Study of TDF Rescue Therapy for Difficult-to-treat CHB Patients: a Comparison Between TDF Monotherapy and TDF-based Combination Therapy","status":"COMPLETED","sponsor":"Yonsei University","startDate":"2014-05-12","conditions":"The Difficult-to-treat Chronic Hepatitis B","enrollment":1020},{"nctId":"NCT01065818","phase":"NA","title":"Early Prediction of Pathology Response of Chemoradiotherapy With FLT PET","status":"TERMINATED","sponsor":"Columbia University","startDate":"2009-08","conditions":"Esophageal Cancer, Non-small Cell Lung Cancer","enrollment":6},{"nctId":"NCT00467545","phase":"PHASE4","title":"An Extension to Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2007-04","conditions":"Chronic Hepatitis B","enrollment":44},{"nctId":"NCT00646503","phase":"PHASE4","title":"Prospective Exploratory Study to Evaluate the Safety and Efficacy of Telbivudine in the Fifth Year of Treatment in Chinese Patients With Compensated Chronic Hepatitis B","status":"COMPLETED","sponsor":"Novartis","startDate":"2008-03","conditions":"Hepatitis B, Chronic","enrollment":150},{"nctId":"NCT00640588","phase":"PHASE3","title":"Prospective Exploratory Study to Describe Hepatitis B Virus (HBV) Kinetics During Treatment With Telbivudine","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2008-03","conditions":"Hepatitis B, Chronic","enrollment":30},{"nctId":"NCT01207895","phase":"PHASE1","title":"Molecular Determinants Affecting Fluoro-L-thymidine (FLT) Positron Emission Tomography (PET) in Rectal Cancer","status":"COMPLETED","sponsor":"Vanderbilt-Ingram Cancer Center","startDate":"2010-03","conditions":"Rectal Cancer","enrollment":5},{"nctId":"NCT00132652","phase":"PHASE3","title":"Switching Therapy From Lamivudine to Telbivudine Versus Continued Lamivudine in Adults With Chronic Hepatitis B","status":"COMPLETED","sponsor":"Novartis","startDate":"2005-02","conditions":"Chronic Hepatitis B","enrollment":240},{"nctId":"NCT01595685","phase":"PHASE3","title":"Telbivudine Versus Entecavir in Reducing Serum HBsAg Levels in Patients With HBeAg-positive Chronic Hepatitis B","status":"COMPLETED","sponsor":"Asan Medical Center","startDate":"2012-05","conditions":"Chronic Viral Hepatitis B Without Delta-agent","enrollment":98},{"nctId":"NCT02894554","phase":"PHASE4","title":"Renal Function Improvement in HBsAg Positive Kidney Transplantation Patients Under Telbivudine Treatment.","status":"TERMINATED","sponsor":"National Taiwan University Hospital","startDate":"2014-07","conditions":"HBsAg-positive Renal Allograft Recipients","enrollment":19},{"nctId":"NCT02826070","phase":"PHASE4","title":"EFFORT Further Extension Study","status":"UNKNOWN","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2015-04","conditions":"Hepatitis B, Chronic","enrollment":130},{"nctId":"NCT01047059","phase":"PHASE2","title":"Molecular Imaging With Erlotinib and Bevacizumab","status":"COMPLETED","sponsor":"University of Cologne","startDate":"2010-01","conditions":"Non-Small-Cell Lung Carcinoma","enrollment":40},{"nctId":"NCT00970216","phase":"","title":"Study of Telbivudine in Chronic Hepatitis B","status":"COMPLETED","sponsor":"Chang Gung Memorial Hospital","startDate":"2009-02","conditions":"Chronic Hepatitis B","enrollment":160},{"nctId":"NCT02241668","phase":"NA","title":"Fluoro-L-Thymidine Positron Emission Tomography (FLT PET) vs. Adv. Magnetic Resonance (MR) Techniques in Recurrent Glioma","status":"WITHDRAWN","sponsor":"M.D. Anderson Cancer Center","startDate":"2015-06","conditions":"Brain Tumor","enrollment":""},{"nctId":"NCT02615639","phase":"PHASE1, PHASE2","title":"A Clinical Trial on Hepatitis B Vaccine Activated-Dendritic Cells Combined With Anti-HBV Drugs in CHB","status":"UNKNOWN","sponsor":"Third Affiliated Hospital, Sun Yat-Sen University","startDate":"2015-11","conditions":"Chronic Hepatitis B","enrollment":450},{"nctId":"NCT02005146","phase":"","title":"Retrospective Observational Study to Define HBsAg Loss With or Without Seroconversion to antiHBs in Patients With Chronic Hepatitis by B Virus Treated With Nucleoside/Nucleotide Analogs","status":"COMPLETED","sponsor":"Fundación Pública Andaluza Progreso y Salud","startDate":"2013-12","conditions":"Chronic Hepatitis B Treated With Nucleoside/Nucleotide Analogues","enrollment":86},{"nctId":"NCT00412529","phase":"PHASE3","title":"Viral Kinetics Study of Telbivudine and Entecavir in Adults With Chronic Hepatitis B","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2006-12","conditions":"Hepatitis B, Chronic Hepatitis B","enrollment":44},{"nctId":"NCT01005238","phase":"PHASE4","title":"Telbivudine Versus Lamivudine for Maintenance Therapy of Patients With Chronic Hepatitis B and Negative HBV Viral Load After 6 Month of Treatment With Telbivudine","status":"TERMINATED","sponsor":"University Hospital, Basel, Switzerland","startDate":"2009-09","conditions":"Hepatitis, Chronic","enrollment":27},{"nctId":"NCT00409019","phase":"PHASE4","title":"Trial of Telbivudine Combination Therapy vs. Continued Adefovir Monotherapy","status":"WITHDRAWN","sponsor":"Novartis Pharmaceuticals","startDate":"","conditions":"Chronic Hepatitis B","enrollment":""},{"nctId":"NCT01637844","phase":"PHASE4","title":"Telbivudine Therapy in HBeAg-positive Pregnant Women to Prevent Mother-to-infant Transmission of HBV","status":"COMPLETED","sponsor":"Yi-Hua Zhou","startDate":"2012-04","conditions":"HBV","enrollment":335},{"nctId":"NCT02253485","phase":"","title":"Efficacy of Antiviral Therapy in Pregnancy in Preventing Vertical Transmission of HBV in Mothers With a High Viral Load","status":"UNKNOWN","sponsor":"Beijing Ditan Hospital","startDate":"2012-08","conditions":"Immune Globulin, Prophylaxis, Telbuvidine, Vaccine","enrollment":600},{"nctId":"NCT01529255","phase":"PHASE4","title":"EFFORT Extension Study","status":"UNKNOWN","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2011-08","conditions":"Hepatitis B, Chronic","enrollment":576},{"nctId":"NCT00651209","phase":"PHASE4","title":"A Single-arm Study Evaluating the Efficacy and Safety of Telbivudine With or Without add-on Tenofovir in Adults With HBeAg-positive Chronic Hepatitis B (CHB)","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2008-02","conditions":"Hepatitis B, Chronic","enrollment":105},{"nctId":"NCT02069418","phase":"PHASE2","title":"Theranostic Tool During Erlotinib Treatment in Non-small Cell Lung Cancer Patient","status":"UNKNOWN","sponsor":"University Hospital, Angers","startDate":"2014-02","conditions":"Non-small Cell Lung Cancer Metastatic or Non-small Cell Lung Cancer Recurrent, No EGFR Activating Mutation","enrollment":80},{"nctId":"NCT01597934","phase":"PHASE4","title":"Antiviral Efficacy of Switching to ETV Plus TDF","status":"UNKNOWN","sponsor":"Yonsei University","startDate":"2012-08","conditions":"Chronic Hepatitis B","enrollment":104},{"nctId":"NCT01958229","phase":"","title":"Efficacy Study of Telbivudine in Chronic Hepatitis B Patients","status":"COMPLETED","sponsor":"National Taiwan University Hospital","startDate":"2009-12","conditions":"Chronic Hepatitis B, Roadmap Concept in Chronic Hepatitis B Treatment, 24-week PCR Negativity of Telbivudine","enrollment":23},{"nctId":"NCT01743079","phase":"PHASE4","title":"Study of Telbivudine and Lamivudine to Prevent Vertical Transmission of Hepatitis B","status":"COMPLETED","sponsor":"Beijing YouAn Hospital","startDate":"2009-01","conditions":"Chronic Hepatitis B, Late Pregnancy, Transmission","enrollment":700},{"nctId":"NCT01788371","phase":"PHASE4","title":"Nucleoside Analogue Prevent Vertical Transmission of Hepatitis B Virus","status":"COMPLETED","sponsor":"Hua Zhang","startDate":"2009-03","conditions":"Hepatitis B Infection, Chronic Infection, Viremia","enrollment":700},{"nctId":"NCT01804387","phase":"PHASE4","title":"Comparison of Telbivudine Plus Adefovir With Lamivudine Plus Adefovir for the Treatment of Lamivudine-resistant Chronic Hepatitis B at 52 Weeks: A Pilot Study","status":"UNKNOWN","sponsor":"Korea University","startDate":"2011-05","conditions":"Chronic Hepatitis B","enrollment":60},{"nctId":"NCT00962533","phase":"PHASE4","title":"EFFicacy Optimization Research of Telbivudine Therapy","status":"COMPLETED","sponsor":"Nanfang Hospital, Southern Medical University","startDate":"2009-08","conditions":"Hepatitis B, Chronic","enrollment":606},{"nctId":"NCT01204827","phase":"PHASE2, PHASE3","title":"Follow Up of Patients Chronic Hepatitis B (CHB) Treated With Sebivo Using the 13C Methacetin Breath Test","status":"WITHDRAWN","sponsor":"Hadassah Medical Organization","startDate":"","conditions":"Chronic Hepatitis B","enrollment":""},{"nctId":"NCT00804622","phase":"PHASE2","title":"Effects of Telbivudine and Tenofovir Disproxil Fumarate on the Kinetics of Hepatitis B Virus DNA in Chronic Hepatitis B (CHB)","status":"COMPLETED","sponsor":"The University of Hong Kong","startDate":"2008-12","conditions":"Chronic Hepatitis B","enrollment":15},{"nctId":"NCT00778596","phase":"PHASE4","title":"Prednisolone Priming Study in Patients With Chronic Hepatitis B","status":"UNKNOWN","sponsor":"Yun-Fan Liaw","startDate":"2009-02","conditions":"Chronic Hepatitis B","enrollment":160},{"nctId":"NCT01595633","phase":"PHASE4","title":"Switch From Adefovir to Tenofovir in Chronic Hepatitis B for Suboptimal Response to Adefovir-based Combination Therapy","status":"UNKNOWN","sponsor":"Yonsei University","startDate":"2012-03","conditions":"Chronic Hepatitis B","enrollment":124},{"nctId":"NCT00877149","phase":"PHASE4","title":"Efficacy of Telbivudine Treatment at Long Term on the Absence of Liver Inflammation in Patients With Compensated Chronic Hepatitis B","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2009-03","conditions":"Compensated Chronic Hepatitis B","enrollment":80},{"nctId":"NCT01588912","phase":"PHASE4","title":"Efficacy of Telbivudine With or Without add-on Tenofovir According to Roadmap Strategy Compare With Entecavir","status":"UNKNOWN","sponsor":"Pusan National University Yangsan Hospital","startDate":"2012-04","conditions":"Chronic Hepatitis B","enrollment":104},{"nctId":"NCT00606099","phase":"PHASE4","title":"Efficacy and Safety of Telbivudine in Patients With Chronic Hepatitis B","status":"WITHDRAWN","sponsor":"Novartis","startDate":"2007-11","conditions":"Chronic Hepatitis B","enrollment":""},{"nctId":"NCT00805675","phase":"PHASE3","title":"Effects of Telbivudine and Tenofovir Disoproxil Fumarate Treatment on the Hepatitis B Virus DNA Kinetics in CHB","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2008-11","conditions":"Hepatitis B Virus","enrollment":83},{"nctId":"NCT01480492","phase":"NA","title":"Effect of Antiviral Therapy on Host Immune in Patients With Chronic Hepatitis B Virus(HBV) Infection","status":"COMPLETED","sponsor":"Cz Li","startDate":"2010-01","conditions":"HBeAg Positive Chronic Hepatitis B Infection","enrollment":56},{"nctId":"NCT00076336","phase":"PHASE3","title":"Telbivudine Versus Lamivudine in Adults With Decompensated Chronic Hepatitis B and Evidence of Cirrhosis","status":"COMPLETED","sponsor":"Novartis Pharmaceuticals","startDate":"2003-12","conditions":"Hepatitis, Hepatitis B, Chronic, Cirrhosis","enrollment":232},{"nctId":"NCT00412750","phase":"PHASE3","title":"Efficacy and Safety of Telbivudine in Treatment naïve Patients With Hepatitis B e Antigen (HBeAg)-Positive Chronic Hepatitis B (CHB)","status":"TERMINATED","sponsor":"Novartis","startDate":"2006-12","conditions":"Hepatitis B","enrollment":159},{"nctId":"NCT00376259","phase":"PHASE3","title":"Study of Combination Therapy With LdT Plus Adefovir Versus Adefovir Alone","status":"TERMINATED","sponsor":"Novartis","startDate":"2007-01","conditions":"Hepatitis B","enrollment":43},{"nctId":"NCT01380951","phase":"PHASE4","title":"Safety and Efficacy of Telbivudine on Liver Cirrhosis in Patients With Chronic Hepatitis B (CHB)","status":"UNKNOWN","sponsor":"The Fifth People's Hospital of Suzhou","startDate":"2011-05","conditions":"Liver Cirrhosis, Chronic Hepatitis B","enrollment":120},{"nctId":"NCT01337791","phase":"PHASE4","title":"Efficacy, Safety and Tolerability of Telbivudine in HBeAg Positive Chronic Hepatitis B Pregnant Women With Elevated Alanine Aminotransferase Levels","status":"COMPLETED","sponsor":"Southeast University, China","startDate":"2008-08","conditions":"Chronic Hepatitis B, Pregnancy Complications, High Viral Load","enrollment":88},{"nctId":"NCT01083251","phase":"NA","title":"The Beneficial Effect of Vitamin D Supplement to Peg Interferon Alpha 2a or to Telbivudine Monotherapy in Patients With Chronic Hepatitis B Virus (HBV) Infection","status":"UNKNOWN","sponsor":"Ziv Hospital","startDate":"2010-03","conditions":"Hepatitis B Virus","enrollment":120},{"nctId":"NCT01155427","phase":"","title":"Systematic Review of Antiretroviral Treatments for Chronic Hepatitis B (CHB)","status":"COMPLETED","sponsor":"Bristol-Myers Squibb","startDate":"2009-05","conditions":"Hepatitis B, Chronic","enrollment":100},{"nctId":"NCT01102335","phase":"PHASE4","title":"Synergistic Treatment for Hepatocellular Carcinoma (HCC) Using Transcatheter Arterial Chemoembolization (TACE) With Anti-hepatitis B Virus (Anti-HBV) Therapy","status":"UNKNOWN","sponsor":"Fudan University","startDate":"2010-04","conditions":"Hepatocellular Carcinoma","enrollment":80},{"nctId":"NCT01089894","phase":"","title":"Clinical Application of 18F-3'-Fluoro-3'-Deoxy-L-thymidine (18F-FLT) Positron Emission Tomography (PET) in Lung Tumors","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2008-08","conditions":"Lung Cancer","enrollment":90},{"nctId":"NCT00939068","phase":"PHASE4","title":"Efficacy and Safety Study of Telbivudine to Prevent Perinatal Transmission","status":"UNKNOWN","sponsor":"Southeast University, China","startDate":"2008-02","conditions":"Chronic Hepatitis B, Gestation","enrollment":180},{"nctId":"NCT00810524","phase":"PHASE4","title":"Influence of Antiviral Treatment to the Long-Term Prognosis of Patients With Chronic HBV Infection","status":"UNKNOWN","sponsor":"Sun Yat-sen University","startDate":"2007-01","conditions":"Hepatitis B, Chronic","enrollment":600}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":0,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":[],"phase":"marketed","status":"active","brandName":"Telbivudine treatment","genericName":"Telbivudine treatment","companyName":"Southeast University, China","companyId":"southeast-university-china","modality":"Small molecule","firstApprovalDate":"","aiSummary":"Telbivudine is a nucleoside reverse transcriptase inhibitor that blocks hepatitis B virus reverse transcriptase, preventing viral replication. Used for Chronic hepatitis B infection.","enrichmentLevel":3,"visitCount":0,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}